|
Volumn 12, Issue 5, 2000, Pages 702-707
|
The clinical value of ferric ammonium citrate: A positive oral contrast agent for T1-weighted MR imaging of the upper abdomen
|
Author keywords
Contrast media, comparative studies; Duodenum; Iron; Magnetic resonance (MR), contrast enhancement; Pancreas, MR; Stomach, MR
|
Indexed keywords
CONTRAST MEDIUM;
FERRIC AMMONIUM CITRATE;
FERRISELTZ;
GERITOL;
ABDOMEN;
ADULT;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTRAST ENHANCEMENT;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC VALUE;
DRUG SAFETY;
DRUG TOLERANCE;
DUODENUM;
GASTROINTESTINAL DISEASE;
HUMAN;
IMAGE ANALYSIS;
MAJOR CLINICAL STUDY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PANCREAS;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SINGLE BLIND PROCEDURE;
STOMACH;
ADMINISTRATION, ORAL;
ADULT;
AGED;
CONTRAST MEDIA;
DUODENUM;
FEMALE;
FERRIC COMPOUNDS;
HUMANS;
IMAGE ENHANCEMENT;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
OBSERVER VARIATION;
PANCREAS;
QUATERNARY AMMONIUM COMPOUNDS;
REPRODUCIBILITY OF RESULTS;
RETROSPECTIVE STUDIES;
SENSITIVITY AND SPECIFICITY;
STOMACH;
|
EID: 0033755061
PISSN: 10531807
EISSN: None
Source Type: Journal
DOI: 10.1002/1522-2586(200011)12:5<702::AID-JMRI6>3.0.CO;2-P Document Type: Article |
Times cited : (16)
|
References (11)
|